A PET scan can show uterine cancer, and it does so with roughly 82% sensitivity and 90% specificity for detecting the primary tumor. That means it catches most uterine cancers, but it’s not perfect. Small tumors and certain tumor types can be missed, and some benign conditions can mimic cancer on the scan. Understanding when a PET scan is most useful, and when other imaging is better, helps make sense of what your results actually mean.
How PET Scans Detect Uterine Cancer
PET scans work by exploiting a basic trait of cancer cells: they consume far more sugar than normal tissue. Before the scan, you receive an injection of a radioactive sugar tracer. Cancer cells, because of their high metabolism, absorb this tracer aggressively and light up on the image. Uterine cancers generally show intense uptake, making them visible against the surrounding tissue.
The catch is that the scan measures metabolic activity, not the shape or structure of a tumor. That means anything metabolically active in the uterus, not just cancer, can light up. And conversely, some cancers are quiet enough to slip through.
What PET Scans Can Miss
Two main factors cause a PET scan to miss uterine cancer. The first is tumor size. PET scanners have a limited spatial resolution, so very small malignant tumors may not register on the image at all. This is known as the partial volume effect: the tumor is simply too small for the machine to distinguish from background tissue. Lesions under about 1 cm are the most likely to be missed.
The second factor is cellular density. Some uterine cancers grow in a loose, spread-out pattern rather than forming a dense mass. These tumors have fewer cancer cells packed into a given area, which means less sugar uptake and a weaker signal on the scan. A tumor that is both small and low in cellular density is the hardest for PET to catch.
False Positives: When the Scan Lights Up Without Cancer
PET positivity is not specific to malignant cells. Several benign conditions in the uterus can absorb the tracer and create a bright spot that looks suspicious. Uterine fibroids (leiomyomas) are the most common culprit. These benign growths can show meaningful tracer uptake due to their blood supply, hormonal activity, and the presence of viable dividing cells. In studies comparing fibroids to uterine sarcomas (a rare uterine cancer), fibroids showed a median metabolic activity score of 4.1, while sarcomas scored a median of 12. There’s overlap in that range, though, which is why a bright spot alone doesn’t confirm cancer.
Infection, active inflammation, scar tissue (fibrosis), and granulomatous conditions like sarcoidosis can also trigger false positives. If your PET scan shows an unexpected finding, your doctor will typically follow up with a biopsy or additional imaging rather than relying on the PET result alone.
Where PET Scans Excel: Staging and Recurrence
PET scans are rarely the first test used to diagnose uterine cancer. A biopsy of the uterine lining is the standard way to confirm a diagnosis. Where PET becomes genuinely valuable is in two specific situations: determining how far a known cancer has spread, and checking whether cancer has come back after treatment.
For staging, PET/CT scans are good at spotting cancer that has traveled to distant lymph nodes or other organs. This whole-body view is something that MRI and ultrasound, which focus on a specific area, don’t provide as efficiently. However, PET/CT is notably weak at assessing how deeply a tumor has invaded the wall of the uterus itself. One study found PET/CT was only about 46% accurate for determining the depth of this local invasion, compared to over 80% accuracy when PET was combined with MRI.
For detecting recurrence, PET scans are remarkably sensitive. In a study of 127 patients who had completed treatment and showed no clinical evidence of disease, PET identified every patient whose cancer had actually returned, achieving 100% sensitivity. It also caught lesions smaller than 1 cm that conventional imaging methods missed. The tradeoff was a false positive rate of about 12%, meaning some patients had to undergo additional testing for findings that turned out to be benign.
PET/CT vs. MRI for Uterine Cancer
Neither scan is universally better. They answer different questions. MRI provides high-resolution images of soft tissue and is the preferred tool for evaluating the uterus itself: how large the tumor is, how deeply it has grown into the uterine wall, and whether it has reached the cervix. PET/CT is better for scanning the entire body to find cancer that has spread to lymph nodes, the lungs, or other distant sites.
Newer machines that combine PET and MRI into a single scan appear to offer the best of both worlds. In a study of 81 patients, integrated PET/MRI achieved 95.5% overall accuracy for detecting regional lymph node spread, compared to 86.5% for PET/CT. For assessing depth of uterine wall invasion, PET/MRI reached about 82% accuracy while PET/CT managed only 46%. These hybrid scanners aren’t available everywhere, but they represent a meaningful improvement when both local detail and whole-body screening are needed.
What the Scan Is Like
You’ll need to fast for at least 8 hours beforehand, though water and your usual medications are fine. If you have diabetes, you’ll be told to skip your diabetes medication the morning of the scan, since blood sugar levels affect how the tracer distributes through your body. After arriving, you’ll receive the tracer through an IV and then rest quietly for about an hour while it circulates. The scan itself typically takes 20 to 40 minutes. You lie still on a table that slides through the scanner. It’s painless, and the radiation exposure is modest, comparable to a CT scan.
Results usually take a few days. Your report will include metabolic activity scores for any areas of concern. Higher scores suggest more aggressive cellular activity, but as noted above, a high score alone doesn’t confirm cancer. Your doctor will interpret the results alongside your biopsy findings, blood work, and any other imaging you’ve had.